Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02587728 · ClinicalTrials.gov registry record
Carpal Tunnel/Amyloidosis Blood Sample Study
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 10
- Enrollment target
NCT02587728: Completed study, sponsored by University of Miami.
NCT02587728 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02587728 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
Carpal tunnel is an early manifestation of amyloidosis in a significant minority of patients. This specimen collection protocol will allow the investigators to screen patients with carpal tunnel syndrome for amyloidosis.
Primary Outcome
Number of carpal tunnel syndrome patients identified with amyloidosis, which will be stratified into mild, moderate or severe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-02-24 |
| Est. Completion | 2017-02-07 |
What the finished NCT02587728 record still lists
NCT02587728 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02587728 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02587728 about?
NCT02587728 is a clinical study titled "Carpal Tunnel/Amyloidosis Blood Sample Study". Carpal tunnel is an early manifestation of amyloidosis in a significant minority of patients. This specimen collection protocol will allow the investigators to screen patients with carpal tunnel syndrome for amyloidosis.
What is the current status of trial NCT02587728?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2016-02-24. Estimated completion is 2017-02-07.
Who is sponsoring clinical trial NCT02587728?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI